A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.


MAISON-BLANCHE P., VERMORKEN J., Goksel T. , MACHIELS J., AGARWALA S., ROTTEY S., ...Daha Fazla

Journal of cardiovascular pharmacology, cilt.61, ss.495-504, 2013 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 61
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1097/fjc.0b013e31828b73ff
  • Dergi Adı: Journal of cardiovascular pharmacology
  • Sayfa Sayıları: ss.495-504